Immediate Impact

3 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

Drug-resistant tuberculosis: a persistent global health concern
2024 Standout
Candida albicans and Candida glabrata : global priority pathogens
2024 Standout
3 intermediate papers

Works of Dan Namarika being referenced

A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis
2012
Combination Flucytosine and High‐Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in Malawi
2009
and 1 more

Author Peers

Author Last Decade Papers Cites
Dan Namarika 282 283 23 60 10 355
Nelly Chentsova 177 161 48 85 9 301
Subhashini A. Sellers 131 233 18 34 11 392
B Salassa 254 224 35 134 17 402
C. Smacchia 117 130 37 75 9 386
Bernd S. Kamps 233 158 32 66 5 355
A Newell 220 195 9 13 14 324
Clement Gascua Adu-Gyamfi 165 189 19 49 15 394
Nkeko Tshabangu 175 193 9 50 10 322
D. A. Cooper 233 93 22 69 9 345
Donald Dietz 193 128 7 36 10 389

All Works

Loading papers...

Rankless by CCL
2026